OncoDaily Leukemia 2024
OncoDaily in collaboration with MDS Foundation, Yerevan State Medical University, Yeolyan Hematology and Oncology Center, Immune Oncology Research Institute and the Armenian Association of Hematology and Oncology is happy to invite you to the OncoDaily Leukemia Conference which will take place on April 25-27 in Yeolyan Hematology and Oncology Center, Yerevan, Armenia.
Join us at the “OncoDaily Leukemia Conference in cooperation with MDS Foundation,” where experts in hematology come to exchange insights, advancements, and strategies in the field of leukemia and related disorders.
To register for the conference please click here.
Save the date: 25-27 April | Entrance: Free
Venue: Yeolyan Hematology and Oncology Center | 7 Nersisyan st., Yerevan, Armenia
Below are several distinguished speakers who will be presenting at the OncoDaily Leukemia Conference and the Agenda of the conference.
Day 1 – April 25
| 09:00-09:30 | Opening |
|
09:30 – 10:10 How I manage Acute Lymphoblastic Leukemia in Children |
Scott Howard, MD (USA) – online Deputy Director of the Yeolyan Hematology and Oncology Center |
|
10:10 – 10:50 How I Manage Acute Lymphoblastic Leukemia in Adults |
Marina Konopleva, MD, PhD (USA) Professor of Oncology and Molecular Pharmacology |
|
10:50 – 11:30 Progress of leukemia research over the past decades: my personal experience |
Giuseppe Saglio, MD, PhD (Italy) Professor of Internal Medicine and Haematology and Director of the Department of Clinical and Biological Sciences at the University of Turin |
| 11:30-12:00 | Coffee Break |
|
12:00 – 12:40 How to diagnose and treat CML in 2024 |
Giuseppe Saglio, MD, PhD (Italy) Professor of Internal Medicine and Haematology and Director of the Department of Clinical and Biological Sciences at the University of Turin |
|
12:40 – 13:20 Bridging the Gap: Translational Research in Hematology |
Sylvain Garciaz MD, PhD (France) – online Professor at Maître de Conférence des Universités- Praticien Hospitalier Département d’hématologie Institut Paoli Calmettes, Marseille, France |
|
13:20 – 14:00 x |
x |
| 14:00-15:00 | Lunch |
|
15.00 – 15:40 Cellular therapies in leukemias |
Nerses Ghahramanyan, MD (Armenia) Chief of the Adults Hematology Outpatient Department at the Yeolyan Hematology and Oncology Center |
|
15:40–16:20 BPDCN: Diagnosis, Treatment, and International Registry |
Astghik Voskanyan, MD (Armenia) Deputy Director and Head of Adult Hematology Clinic at the Yeolyan Hematology and Oncology Center; Clinical Research Physician and Lead of Hematology at the Immune Oncology Research Institute; PI of the BPDCN International Registry |
|
16:20 – 17:00 Understanding Cutaneous T-Cell Lymphomas: Classification, Diagnosis, and Treatment |
Lusine Harutyunyan, MD (Armenia) Hematologist at the Yeolyan Hematology and Oncology Center; Research Fellow at the Immune Oncology Research Institute |
|
17:00-17:40 Vexas Syndrome and MDS |
Arsene Mekinan, MD, PhD (France) – online Professor of Medicine at the University of Paris; Visiting Professor at Yerevan State Medical University; President of Santé Arménie |
|
17:40-18:00 |
Closing |
Day 2 – April 26
|
09:30 – 10:10 Molecular Advances in the Understanding of Myelodysplastic Syndromes (MDS) |
Peter Greenberg, MD (USA) – online Professor of Medicine and Director of the Stanford MDS Center, Stanford University |
|
10:10 – 10:50 Cutting-Edge Therapeutic Strategies for Acute Myeloid Leukemia (AML) |
Marina Konopleva, MD, PhD (USA) Professor of Oncology and Molecular Pharmacology, Director of the Leukemia Program, Co-Director of the Blood Cancer Institute at Montefiore Einstein, Professor of Leukemia Department at MD Anderson Cancer Center |
|
10:50-11:30 Case Report Session |
Nare Martirosyan, MD (Armenia)
Hematologist at the Yeolyan Hematology and Oncology Center Meri Petrosyan, MD (Armenia) Pediatric oncologist and hematologist, a fellow of clinical immunology at Yeolyan Hematology and Oncology Center |
|
11:30 – 12:10 Conducting Phase 1 trials: challenges and opportunities
|
Mikhail Groubman, PhD (Russia) CEO of Atlant Clinical; Chair of the Board of the Immune Oncology Research Institute |
|
12:10-12:20
|
Coffee Break |
|
12:20 – 13:20 Case Report Session |
Araksia Vanoyan, MD (Armenia)
Hematologist at the Yeolyan Hematology and Oncology Center Grigor Vardanyan, MD (Armenia) Hematologist at the Yeolyan Hematology and Oncology Center Hasmik Maghakyan, MD (Armenia) Medical Resident at the Yeolyan Hematology and Oncology Center |
|
14:00-15:00
|
Lunch
|
|
15:00 – 15:40 Diagnosis and Management of Patients with MDS in Armenia |
Anna Sevoyan, MD (Armenia) Hematologist at the Yeolyan Hematology and Oncology Center |
|
15:40 – 16:20 How I Treat Low Risk MDS |
Gabriele Todisco (Italy) – online Assistant Professor at Humanitas University |
|
16:20 – 17:00 How I Treat High Risk MDS |
Rami Komrokji, MD (USA) – online Vice chair of Malignant Hematology Department and Head of the Leukemia and MDS Section at Moffitt Cancer Center; Professor of Medicine & Oncologic Sciences at the College of Medicine at the University of South Florida |
|
17:00 – 17:40 Updates to Diagnosis/Classification of MDS and AML |
Robert Hasserjian, MD (USA) – online Director, Hematopathology Fellowship Program, Pathology Service at Massachusetts General Hospital; Professor of Pathology at the Harvard Medical School |
|
17:40-18:00 |
Closing |
Day 3 – April 27
|
10:00 – 10:40 Development of Oral Azacitidine with Cedazuridine for Myelodysplastic Syndrome (MDS) and Myeloproliferative Neoplasms (MPN) including CMML (Chronic Myelomonocytic Leukemia) by Targeting Pharmacokinetic AUC Equivalence vs Subcutaneous Azacitidine |
Aram Oganesian, PhD, DABT (USA) Vice-President, Clinical Pharmacology Taiho Oncology |
| MDS Patient Forum
10:40 – 12:00 |
Anna Sevoyan, MD (Armenia) Hematologist at the Yeolyan Hematology and Oncology Center |